Independent Financial Information Made Easy
The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.
Apellis Pharmaceuticals Inc. (APLS) stock has risen 9% while the S&P 500 has fallen -0.6% as of 1:14 PM on Friday, Oct 13. The company has a Bullish sentiment reading. Wall Street Analysts Think 67.65% The mean of analysts price targets for Apellis Pharmaceuticals, Inc. (apls) stock price, news, quote & history - yahoo finance.com Insider Sell: Pascal Deschatelets Sells 12,000 Shares. Apellis Pharmaceuticals Inc (APLS) price may drop as it broke higher Bollinger Band on Oct 13, 2023. This price move could be a signal that APLS may fall back below the higher band. Apellis Pharmaceuticals, Inc. (APLS) Investors have opportunity to lead a class action lawsuit against the Company. Apellis Pharmaceuticals traded as high as $50.49 and last traded at $49.47. The company has a market cap of $5.70 billion, a price-to-earnings ratio of -8.31. Hedge funds and other institutional investors have recently added to or reduced their stakes in APLS. Apellis Pharmaceuticals stock (NASDAQ: APLS) stock price, news, charts, stock research, profile. Daily Ratings & News for Apelli Pharmaceuticals. Complete the form below to receive the latest headlines.
Open: 63.98 Close: 63.8 Change: -0.18
Read more →Open: 44.15 Close: 48.44 Change: 4.29
Read more →